Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2025-06-10 00:00:00 ET · period of report 2025-06-09 · accession 0001437749-25-019958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-10 | 2025-06-09 | AYTU | Disbrow Jarrett | Chief Business Off | P - Purchase | $1.50 | +16.7K | 29.5K | +130% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-09 | P | A | 16,666 | $1.50 | 29,462 | D | — | — | (F1) Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025. (F2) Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023. |